Assignment and Waiver AgreementAssignment and Waiver Agreement • August 5th, 2024 • CBI USA, Inc. • Pharmaceutical preparations
JOINT FILING AGREEMENTJoint Filing Agreement • June 28th, 2023 • CBI USA, Inc. • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the shares of the Common Stock of the Company and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 23rd day of June, 2023.
AmendmentCBI USA, Inc. • July 2nd, 2024 • Pharmaceutical preparations
CBI USA, INC. (“CBI USA”) and DGP CO., LTD. (“DGP”) have entered into this Amendment (this “Amendment”) to amend the Stock Loan Agreement dated February 29, 2024 (the “Original Agreement”) and agree as follows:
Stock Loan AgreementStock Loan Agreement • March 4th, 2024 • CBI USA, Inc. • Pharmaceutical preparations
Second AmendmentSecond Amendment • August 5th, 2024 • CBI USA, Inc. • Pharmaceutical preparations
Stock Purchase AgreementStock Purchase Agreement • March 4th, 2024 • CBI USA, Inc. • Pharmaceutical preparations
AmendmentUnderlying Agreement • July 2nd, 2024 • CBI USA, Inc. • Pharmaceutical preparations
Joint Filing AgreementJoint Filing Agreement • February 14th, 2023 • CBI USA, Inc. • Pharmaceutical preparations
The undersigned hereby agree that the Statement on Schedule 13G dated February 14, 2023 with respect to the Common Stock, $0.001 par value per share of Kineta, Inc., a Delaware corporation, and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
ASSIGNMENT OF RIGHTSAssignment of Rights • June 28th, 2023 • CBI USA, Inc. • Pharmaceutical preparations • Delaware
This Assignment (this “Assignment”) is made and entered into this 23rd day of June, 2023, by and between CBI USA, Inc., a Delaware corporation (“Assignor”), and DGP Co., Ltd., a corporation organized under the Laws of Korea, formerly known as Daehan Green Power Corporation (“Assignee”).
